Boost and Burn.

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

• Studied in people17 human studies on Caffeine back this formula, each one cited.
• A mechanism that is settledHow KSM-66 Ashwagandha and Chromax Chromium Picolinate work is settled pharmacology.
• Studied together, not just separatelyKSM-66 Ashwagandha and Caffeine have been studied together, not only separately.
• Recent work on the recordThe most recent study on this record was published in 2026.
• Serving amount inside the studied rangeEach serving carries 200 mcg of Chromax Chromium Picolinate, inside the range the published research used.
• A stated daily maintenance amountChromax Chromium Picolinate is here at a daily maintenance amount, which is what a daily supplement is for.
• Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
• The exact form, describedThe label names its forms exactly: Root extract powder standardised to withanolide glycosides, Chromium picolinate, Citrus aurantium peel powder. The record says what each one is and what it suits.
• Full label disclosureEvery ingredient on this label carries its own declared amount.
• Where it comes from and how it is madeKSM-66 Ashwagandha is made by botanical.
• Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
• A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

• KSM-66 Ashwagandhaabout eight to nine weeks of daily useBuilds with daily use

  In a 60 day randomised, double-blind, placebo-controlled trial, 60 stressed healthy adults took 240 mg of a standardised ashwagandha extract (Shoden) once daily or placebo. The ashwagandha arm showed a larger fall in Hamilton Anxiety Rating Scale scores (p = .040) and in morning cortisol (p < .001) than placebo, with the DASS-21 change near-significant (p = .096). A separate 8 week randomised, double-blind, placebo-controlled dose-ranging trial enrolled 131 adults with self-reported high stress and analysed 98, measuring reduced Perceived Stress Scale scores at 125, 250 and 500 mg per day of an aqueous root and leaf extract. Two trials on two different extracts, both landing in the same eight to nine week band.

  Lopresti et al., 2019 (Medicine)PMID 31517876

  Pandit et al., 2024 (Nutrients)PMID 38732539

  Promising
• Caffeinewithin about 45 to 60 minutes of a single doseMeasured within a day

  In a double-blind placebo-controlled crossover trial, 15 resistance-trained women took 4 mg per kg body mass of caffeine 60 minutes before a strength and power battery. Squat one-repetition maximum rose 4.5 percent and countermovement jump height 7.6 percent against placebo. A separate crossover trial in 11 active adults began its cycling tests 45 minutes after a 3 mg per kg capsule and recorded a peak-power increase of about 4 percent on the first day of ingestion.

  Norum et al., 2020PMID 32681596

  Lara et al., 2019PMID 30673725

  Promising
• Caffeineheld for about 15 to 18 days of daily use, then narrowedBuilds with daily use

  One crossover trial mapped the day-to-day time course in 11 healthy active adults taking 3 mg per kg per day for 20 consecutive days. Peak cycling power in the incremental test stayed about 4.0 percent above placebo for the first 15 days and the difference then lessened. Wingate peak power was still raised on days 1, 4, 15 and 18 by about 4.9 percent. The authors describe the shrinking margin as progressive tolerance. This is one trial with 11 participants.

  Lara et al., 2019PMID 30673725

  Early
• Cordycepswithin the hour of a single doseMeasured within a day

  In a randomised, double-blind, placebo-controlled crossover in 12 recreationally active young men, a single 1 g dose of standardised Cordyceps militaris extract taken 30 minutes before a maximal cycling test was followed by faster Stroop reaction times across the session compared with placebo.

  Farzan et al., 2026 (PLoS One)PMID 42455764

  Early

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

How each ingredient usually behaves over time.

Five ingredients, from each one's own page.

• KSM-66 Ashwagandha

  Most of the change lands between weeks four and eight of daily use. Some people notice easier evenings inside the first two weeks.

  Its own page, the plain answer on timing ↗

• Chromax Chromium PicolinateWeeks, not days

  It acts on insulin signalling quietly, so the change shows up on a glucose panel rather than as a moment you could point to.

  Its own page, the plain answer on timing ↗

• Advantra Z Bitter OrangeAbout 30 to 60 minutes

  Of a dose: a little warmth, a small lift in heart rate and less pull toward the next snack. It fades over several hours.

  Its own page, the plain answer on timing ↗

• CaffeineThirty to sixty minutes

  To peak in the blood, and most people notice the shift in alertness inside that first hour. The strongest point lands around ninety minutes.

  Its own page, the plain answer on timing ↗

• CordycepsAbout three to four weeks

  Give it three to four weeks of daily use. Any change shows up in how a hard session goes rather than as something you notice on the first day.

  Its own page, the plain answer on timing ↗

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

The same ingredient, carried differently.

What each form is, and where it fits in a formula. Measured findings carry the study that reported them.

• Chromium picolinate

  A neutral coordination complex of trivalent chromium bound to three picolinic acid ligands. Picolinic acid is the same molecule the body forms from tryptophan, here acting as the carrier around a single chromium centre.

  Fits

  The most widely used chromium form in retail supplements. A stable, well-characterised complex that works in dry capsules, tablets and powders and supplies chromium at the microgram doses typical of the category.

  Trade-off

  The picolinate ligand has drawn research scrutiny over its redox behaviour at high intake in laboratory work, and it is a distinct synthesised molecule rather than the chromium as it occurs in food.

  In a six-month double-blind, placebo-controlled pilot trial in 24 overweight adults with binge eating disorder, chromium picolinate at 600 or 1000 micrograms per day was associated with lower fasting glucose than placebo, with a larger reduction in the higher-dose group. Fasting glucose is a metabolic marker, not a clinical endpoint.

  Brownley et al., 2013 (J Psychosom Res)PMID 23751236

Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.

Capsule

It is a capsule, so the amount per serving is fixed and travels without measuring.